Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies

Despite consistent progress in prompt diagnosis and curative therapies in the last decade, lung cancer (LC) continues to threaten mankind, accounting for nearly twice the casualties compared to prostate, breast, and other cancers. Statistics associate ~25% of 2021 cancer-related deaths with LC, more...

Full description

Bibliographic Details
Main Authors: Parth Malik, Ruma Rani, Raghu Solanki, Vishal Haribhai Patel, Tapan Kumar Mukherjee
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2023-01-01
Series:Exploration of Targeted Anti-tumor Therapy
Subjects:
Online Access:https://www.explorationpub.com/Journals/etat/Article/1002171